Concord Biotech share price
You have to be logged in to add this to Watchlist.Concord Biotech is trading 2.06% upper at Rs 2,073.30 as compared to its last closing price. Concord Biotech has been trading in the price range of 2,099.95 & 2,002.20. Concord Biotech has given 37.20% in this year & 8.93% in the last 5 days.
Concord Biotech has TTM P/E ratio 54.87 as compared to the sector P/E of 33.29.There are 3 analysts who have initiated coverage on Concord Biotech. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of 95.74 Crores in its last quarter.
Listed peers of Concord Biotech include Emcure Pharmaceuticals (0.30%), Nuvama Wealth Management (1.52%), Concord Biotech (2.06%) etc.
Concord Biotech has a 55.92% public holding.The Mutual Fund holding in Concord Biotech was at 4.97% in 30 Sep 2024. The MF holding has decreased from the last quarter. The FII holding in Concord Biotech was at 8.10% in 30 Sep 2024. The FII holding has increased from the last quarter.
Concord Biotech share price range
|
| ||||
|
| ||||
Concord Biotech share Key Metrics
| Market Cap ( ₹ Cr.) | 21,125.15 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Concord Biotech Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 11-Nov-24 | Quarterly Results |
| 09-Aug-24 | Quarterly Results |
| 23-May-24 | Audited Results & Dividend |
| 08-Feb-24 | Quarterly Results |
| 08-Nov-23 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 29-Jun-24 | 14-Jun-24 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 23-May-24 | 22-Jun-24 | 21-Jun-24 | 8.75 |
FAQs about Concord Biotech share price
Concord Biotech is trading at 2073.30 as on Mon Nov 25 2024 09:59:42. This is 2.06% upper as compared to its previous closing price of 2031.55.
The market capitalization of Concord Biotech is 21125.15 Cr as on Mon Nov 25 2024 09:59:42.
The average broker rating on Concord Biotech is Buy. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 1 analysts have given a hold rating
- 0 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Concord Biotech is 2658.00 whereas the 52 wk low is 1206.00
Concord Biotech can be analyzed on the following key metrics -
- TTM P/E: 54.87
- Sector P/E: 33.29
- Dividend Yield: 0.43%
- D/E ratio: 0.00
Concord Biotech reported a net profit of 308.10 Cr in 2024.
Concord Biotech Quick Links
Concord Biotech Dividend Concord Biotech Bonus Concord Biotech News Concord Biotech AGM Concord Biotech Rights Concord Biotech Splits Concord Biotech Board Meetings Concord Biotech Key Metrics Concord Biotech Shareholdings Concord Biotech Profit Loss Concord Biotech Balance Sheet Concord Biotech Cashflow Concord Biotech Q1 Results Concord Biotech Q2 Results Concord Biotech Q3 Results Concord Biotech Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks